Please join us for an educational inservice with Dr. Mark Bernstein, Senior Director for Medical Scientists at Gilead Pharmaceuticals. Dr. Bernstein will be discussing the use of Truvada for pre-exposure prophylaxis among HIV-negative people at high risk for new HIV infections. This is a presentation of Gilead Community Medical Affairs. Lunch will be provided.
To RSVP, please call Anthony at (914) 785-8277 or email him at aaccomando@hudsonvalleycs.org.